Medical Condition News

RSS

Online instructional video improves patient compliance with colonoscopy

Patients who watch an online instructional video are more likely to keep their appointments and arrive prepared for a scheduled colonoscopy than those who do not, according to a study by gastroenterologists at the University of Chicago Medicine.

21 May 2012

Three-drug combo harmful for patients with idiopathic pulmonary fibrosis

A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary fibrosis, according to the surprising results of a rigorous independent study.

21 May 2012

Sleep-disordered breathing may increase risk of cancer mortality

Sleep-disordered breathing (SDB), commonly known as sleep apnea, is associated with an increased risk of cancer mortality, according to a new study.

21 May 2012

POZEN presents data from PA32540 Phase 1 gastric acid reduction study at DDW 2012

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from a Phase 1 study that found that the investigational compound, PA32540, provides faster protection compared with delayed-release, enteric-coated omeprazole (40 mg), as measured by mean time to gastric pH.

21 May 2012

Santarus to present UCERIS Phase III trial data on ulcerative colitis at DDW meeting

Santarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the investigational drug UCERIS (budesonide) 6 mg tablets will be featured in four poster presentations at the Digestive Disease Week (DDW) Meeting being held at the San Diego Convention Center on May 19 - 22, 2012.

19 May 2012

Receptos to present scientific podium presentation about RPC1063 at DDW 2012

Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week (DDW) annual meeting at 9 a.m. PDT on Sunday, May 20, 2012 at the San Diego Convention Center in San Diego, California. DDW attracts thousands of physicians, researchers, and academics from around the world to share the latest research in gastrointestinal health topics, for which DDW is the premier scientific conference.

19 May 2012

Ceregene announces new data from CERE-120 clinical trial on Parkinson's

Ceregene Inc., a biotechnology company developing treatments for neurodegenerative diseases such as Parkinson's disease, will present new data demonstrating long-term, biologically-active expression of neurturin, a nervous system growth factor delivered to the degenerating dopamine nerves in patients with Parkinson's disease following treatment with CERE-120.

19 May 2012

Quest Diagnostics introduces four new tests panels for CAH

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder found in newborns, children and women.

From Quest Diagnostics 19 May 2012

LKCF, Spirit of Women’s HeartCaring to help reduce disparities in diagnosis and care

In an ongoing effort to save the lives of thousands of Americans at risk of cardiovascular ailments each year, Spirit of Women Health Network has joined forces with the Larry King Cardiac Foundation (LKCF) to help reduce the devastating disparity in the diagnostics, clinical care, and survival rate of heart attacks, strokes and other heart events for women and people of color.

19 May 2012

Clinical data from Boston Scientific endoscopy studies to be presented at DDW

Boston Scientific Corporation announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week (DDW), May 19 – 22 in San Diego.

19 May 2012

New study to find best way to give blood transfusions for severely injured patients

Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.

19 May 2012

Certain types of fat associated with worse memory and overall cognitive function

It has been known for years that eating too many foods containing "bad" fats, such as saturated fats or trans fats, isn't healthy for your heart. However, according to new research from Brigham and Women's Hospital (BWH), one "bad" fat-saturated fat-was found to be associated with worse overall cognitive function and memory in women over time. By contrast, a "good" fat-mono-unsaturated fat was associated with better overall cognitive function and memory.

19 May 2012

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

Purdue Pharma L.P. will present an analysis of data from completed clinical trials for Butrans® (buprenorphine) Transdermal System CIII at the American Pain Society's (APS) 31st Annual Scientific Meeting.

19 May 2012

Palliative care interventions may boost overall survival of cancer patients

Recent studies have shown that palliative care interventions aimed at addressing patients' emotional, spiritual and social needs have a significant impact on cancer patients' quality of life and may even improve cancer patients' overall survival. Despite this, most cancer patients being cared for in their communities do not have access to these services.

19 May 2012

Crownsville student receives Gordon E. Moore Award for pancreatic cancer test

Jack Andraka, 15, of Crownsville, Md. was awarded first place for his new method to detect pancreatic cancer at this year's Intel International Science and Engineering Fair, a program of Society for Science & the Public. Based on diabetic test paper, Jack created a simple dip-stick sensor to test blood or urine to determine whether or not a patient has early-stage pancreatic cancer.

19 May 2012

FDA gives patients less-expensive option, approves first generic versions of Plavix

Patients taking the popular blood thinner Plavix now have the option of getting a less-expensive pill, following the approval Thursday of the first generic versions in the U.S. That's because the patent for Plavix, the world's second-best-selling medicine, just expired. Plavix is taken by millions of people every day to prevent heart attacks and strokes, by preventing platelets in the blood from clumping together.

19 May 2012

Urologic conditions contribute to major economic burden in the U.S.

Urologic conditions like urinary tract infections, kidney stones, and prostate cancer are a major economic burden on Americans, resulting in health care costs of close to $40 billion annually, according to a newly released national report that charts the demographic and economic impact of urologic diseases in the U.S.

19 May 2012

Final results from C3BS-CQR-1 Phase II trial on heart failure

The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces that the final results of its Phase II clinical trial of C3BS-CQR-1 is will be presented at the late breaking clinical trial session at the European Society of Cardiology 2012 Heart Failure Congress in Belgrade, Serbia taking place on May 19-22.

19 May 2012

Bullying becomes hot topic in the U.S.

Bullying has become a hot topic in the U.S., hitting a cultural nerve as evidenced by the buzz surrounding the recent release of a documentary called "Bully" as well as a book entitled The Bully Society: School Shootings and the Crisis of Bullying in America's Schools.

19 May 2012

Data from Almirall, Forest Labs’ aclidinium studies on COPD to be presented at ATS conference

Forest Laboratories, Inc. and Almirall, S.A. today announced that they will present aclidinium-related data in 1 poster discussion session and 3 poster presentations at the American Thoracic Society (ATS) International Conference scheduled May 18 - 23 in San Francisco, CA.

19 May 2012

Medical Condition News

Online instructional video improves patient compliance with colonoscopy

Three-drug combo harmful for patients with idiopathic pulmonary fibrosis

Sleep-disordered breathing may increase risk of cancer mortality

POZEN presents data from PA32540 Phase 1 gastric acid reduction study at DDW 2012

Santarus to present UCERIS Phase III trial data on ulcerative colitis at DDW meeting

Receptos to present scientific podium presentation about RPC1063 at DDW 2012

Ceregene announces new data from CERE-120 clinical trial on Parkinson's

Quest Diagnostics introduces four new tests panels for CAH

LKCF, Spirit of Women’s HeartCaring to help reduce disparities in diagnosis and care

Clinical data from Boston Scientific endoscopy studies to be presented at DDW

New study to find best way to give blood transfusions for severely injured patients

Certain types of fat associated with worse memory and overall cognitive function

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

Palliative care interventions may boost overall survival of cancer patients

Crownsville student receives Gordon E. Moore Award for pancreatic cancer test

FDA gives patients less-expensive option, approves first generic versions of Plavix

Urologic conditions contribute to major economic burden in the U.S.

Final results from C3BS-CQR-1 Phase II trial on heart failure

Bullying becomes hot topic in the U.S.

Data from Almirall, Forest Labs’ aclidinium studies on COPD to be presented at ATS conference

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News